http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 535 reviews. 535 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Zeclar OD

Choose a suitable interchangeable generic or brand drug, if you could not find the prescribed medicine.
We do not sell drugs. This site contains prices only for information purposes to help you buy drugs cheaply.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Zeclar OD uses and description

Sort by popularity
Zeclar OD - Pharmacology: Binds to the 50S ribosomal subunit of susceptible microorganisms, resulting in inhibition of protein synthesis.

Indication: Adults Immediate-release tablets and oral suspension

Treatment of pharyngitis/tonsillitis; acute maxillary sinusitis; acute bacterial exacerbation of chronic bronchitis; community-acquired pneumonia; uncomplicated skin and skin structure infections; disseminated mycobacterial infections; Helicobacter pylori and duodenal ulcer disease when used in combination with amoxicillin and lansoprazole or omeprazole; H. pylori and active duodenal ulcer when used in combination with omeprazole or ranitidine bismuth citrate; prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection; treatment of disseminated mycobacterial infections caused by M. avium or Mycobacterium intracellulare.

ER tablets

Treatment of acute maxillary sinusitis; acute bacterial exacerbation of chronic bronchitis; community-acquired pneumonia.

Children Immediate-release tablets and oral suspension

Pharyngitis/tonsillitis; community-acquired pneumonia; acute maxillary sinusitis; acute otitis media; uncomplicated skin and skin structure infections; prevention of disseminated MAC disease in children with advanced HIV infection; treatment of M. avium or M. intercellulare.

Zeclar OD is a macrolide antibiotic. Zeclar OD fights bacteria in your body.

Zeclar OD is used to treat many different types of bacterial infections affecting the skin and respiratory system. Zeclar OD is also used together with other medicines to treat stomach ulcers caused by Helicobacter pylori.

Zeclar OD may also be used for purposes not listed in this medication guide.

Used for: Treating infections caused by certain bacteria.

Zeclar OD is a macrolide antibiotic. It works by stopping the growth of or killing sensitive bacteria by reducing the production of important proteins needed by the bacteria to survive.

Zeclar OD is a macrolide antibiotic whose spectrum of activity includes many gram-positive (Staphylococcus aureus, S. pneumoniae, and S. pyogenes) and gram-negative aerobic bacteria (Haemophilus influenzae, H. parainfluenzae, and Moraxella catarrhalis), many anaerobic bacteria, some mycobacteria, and some other organisms including Mycoplasma, Ureaplasma, Chlamydia, Toxoplasma, and Borrelia. Other aerobic bacteria that Zeclar OD has activity against include C. pneumoniae and M. pneumoniae. Zeclar OD has an in-vitro activity that is similar or greater than that of erythromycin against erythromycin-susceptible organisms. Zeclar OD is usually bacteriostatic, but may be bactericidal depending on the organism and the drug concentration.

Zeclar OD is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs or skin Zeclar OD can also be used to prevent infection when you undergo certain dental procedures. Zeclar OD is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Zeclar OD belongs to a group of antibiotics called the macrolides.

Oral Susceptible infections

Adult: 250 mg bid increased to 500 mg bid for severe infections if necessary for 7-14 days.

Child: 7.5 mg/kg bid for 5-10 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Respiratory tract infections

Adult: 250 mg bid increased to 500 mg bid for severe infections if necessary for 7-14 days.

Child: 7.5 mg/kg bid for 5-10 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Skin and soft tissue infections

Adult: 250 mg bid increased to 500 mg bid for severe infections if necessary for 7-14 days.

Child: 7.5 mg/kg bid for 5-10 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Mycobacterium avium complex infections

Adult: 500 mg bid in combination with other antimycobacterials.

Child: 7.5 mg/kg bid; to be used with other antimycobacterials. May increase dose to 15 mg/kg (max: 500 mg) bid. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Leprosy

Adult: 500 mg daily as part of an alternative multidrug therapy. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Eradication of H. pylori associated with peptic ulcer disease

Adult: 500 mg bid; given in combination with another antibacterial and either a proton pump inhibitor or H 2 -receptor antagonist for 7-14 days.

Child: ≥1 yr: 7.5 mg/kg bid; may be given with another antibacterial and a proton pump inhibitor for 7 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Intravenous Respiratory tract infections

Adult: 500 mg bid for 2-5 days. Dose to be infused over 60 minutes in a 0.2% solution; revert to oral therapy whenever possible.

Child: 1 mth-12 yr: 7.5 mg/kg every 12 hr. Dose to be given via infusion into proximal vein. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Intravenous Skin and soft tissue infections

Adult: 500 mg bid for 2-5 days. Dose to be infused over 60 minutes in a 0.2% solution; revert to oral therapy whenever possible.

Child: 1 mth-12 yr: 7.5 mg/kg every 12 hr. Dose to be given via infusion into proximal vein. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Intravenous Susceptible infections

Adult: 500 mg bid for 2-5 days. Dose to be infused over 60 minutes in a 0.2% solution; revert to oral therapy whenever possible.

Child: 1 mth-12 yr: 7.5 mg/kg every 12 hr. Dose to be given via infusion into proximal vein. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval.

Indications:

Adult: PO Resp tract infections; Skin and soft tissue infections; Susceptible infections 250 mg twice daily, up to 500 mg twice daily for severe infections, for 7-14 days. Mycobacterium avium complex infections W/ other antimycobacterials: 500 mg twice daily. Leprosy As part of multidrug therapy: 500 mg/day. H. pylori infection W/ another antibacterial and either a proton pump inhibitor or H 2 antagonist: 500 mg twice daily for 7-14 days. IV Resp tract infections; Skin and soft tissue infections; Susceptible infections 500 mg twice daily for 2-5 days.

Oral Susceptible infections

Adult: 250 mg bid increased to 500 mg bid for severe infections if necessary for 7-14 days.

Child: 7.5 mg/kg bid for 5-10 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Respiratory tract infections

Adult: 250 mg bid increased to 500 mg bid for severe infections if necessary for 7-14 days.

Child: 7.5 mg/kg bid for 5-10 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Skin and soft tissue infections

Adult: 250 mg bid increased to 500 mg bid for severe infections if necessary for 7-14 days.

Child: 7.5 mg/kg bid for 5-10 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Infections due to Mycobacterium avium complex (MAC)

Adult: 500 mg bid in combination with other antimycobacterials.

Child: 7.5 mg/kg bid; to be used with other antimycobacterials. May increase dose to 15 mg/kg (max: 500 mg) bid. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Leprosy

Adult: 500 mg daily as part of an alternative multidrug therapy. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Oral Eradication of H. pylori associated with peptic ulcer disease

Adult: 500 mg bid in combination with either a proton pump inhibitor or H 2 -receptor antagonist for 7-14 days.

Child: ≥1 yr: 7.5 mg/kg bid; may be given with another antibacterial and a proton pump inhibitor for 7 days. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Intravenous Respiratory tract infections

Adult: 500 mg bid for 2-5 days. Dose to be infused over 60 minutes in a 0.2% solution; revert to oral therapy whenever possible.

Child: 1 mth–12 yr: 7.5 mg/kg every 12 hr. Dose to be given via infusion into proximal vein. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Intravenous Skin and soft tissue infections

Adult: 500 mg bid for 2-5 days. Dose to be infused over 60 minutes in a 0.2% solution; revert to oral therapy whenever possible.

Child: 1 mth–12 yr: 7.5 mg/kg every 12 hr. Dose to be given via infusion into proximal vein. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval. Intravenous Susceptible infections

Adult: 500 mg bid for 2-5 days. Dose to be infused over 60 minutes in a 0.2% solution; revert to oral therapy whenever possible.

Child: 1 mth–12 yr: 7.5 mg/kg every 12 hr. Dose to be given via infusion into proximal vein. CrCl (ml/min) Dosage Recommendation <30 Half the dosage or double dosing interval.

for the treatment of mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions as listed below:Adults (Filmtab Tablets and Granules for Oral Suspension)Pharyngitis/Tonsillitis due to Streptococcus pyogenes (The usual drug of choice in the treatment and prevention of streptococcal infections and the prophylaxis of rheumatic fever is penicillin administered by either the intramuscular or the oral route. Zeclar OD is generally effective in the eradication of S. pyogenes from the nasopharynx; however, data establishing the efficacy of Zeclar OD in the subsequent prevention of rheumatic fever are not available at present).Acute maxillary sinusitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Acute bacterial exacerbation of chronic bronchitis due to Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Community-Acquired Pneumonia due to Haemophilus influenzae, Mycoplasma pneumoniae, Streptococcus pneumoniae, or Chlamydia pneumoniae (TWAR).Uncomplicated skin and skin structure infections due to Staphylococcus aureus, or Streptococcus pyogenes (Abscesses usually require surgical drainage).Disseminated mycobacterial infections due to Mycobacterium avium, or Mycobacterium intracellulare(clarithromycin) Filmtab tablets in combination with amoxicillin and PREVACID (lansoprazole) or PRILOSEC (omeprazole) Delayed-Release Capsules, as triple therapy, are indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or five-year history of duodenal ulcer) to eradicate H. pylori. Filmtab tablets in combination with PRILOSEC (omeprazole) capsules or TRITEC (ranitidine bismuth citrate) tablets are also indicated for the treatment of patients with an active duodenal ulcer associated with H. pylori infection. However, regimens which contain Zeclar OD as the single antimicrobial agent are more likely to be associated with the development of Zeclar OD resistance among patients who fail therapy. Clarithromycin-containing regimens should not be used in patients with known or suspected Zeclar OD resistant isolates because the efficacy of treatment is reduced in this setting. In patients who fail therapy, susceptibility testing should be done if possible. If resistance to Zeclar OD is demonstrated, a non-clarithromycin-containing therapy is recommended. (For information on development of resistance see Microbiology section.) The eradication of H. pylori has been demonstrated to reduce the risk of duodenal ulcer recurrence. Children (Filmtab Tablets and Granules for Oral Suspension)Pharyngitis/Tonsillitis due to Streptococcus pyogenes. Community-Acquired Pneumonia due to Mycoplasma pneumoniae, Streptococcus pneumoniae, or Chlamydia pneumoniae (TWAR)Acute maxillary sinusitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniaeAcute otitis media due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniaeNOTE: For information on otitis media, see Clinical Studies - Otitis Media. Uncomplicated skin and skin structure infections due to Staphylococcus aureus, or Streptococcus pyogenes (Abscesses usually require surgical drainage.)Disseminated mycobacterial infections due to Mycobacterium avium, or Mycobacterium intracellulareAdults (Filmtab Tablets) Filmtab (clarithromycin extended-release tablets) are indicated for the treatment of adults with mild to moderate infection caused by susceptible strains of the designated microorganisms in the conditions listed below:Acute maxillary sinusitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniaeAcute bacterial exacerbation of chronic bronchitis due to Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or Streptococcus pneumoniaeCommunity-Acquired Pneumonia due to Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Streptococcus pneumoniae, Chlamydia pneumoniae (TWAR), or Mycoplasma pneumoniae

Indications: URTI, pharyngitis and sinusitis, LRTI, bronchitis and pneumonia, skin and soft tissue infection.

H.

Pylori infection.

Infection due to Mycobacterium avium complex (MAC).

Active ingredients: Clarithromycin
Unit description, dosagePrice, USD

List of zeclar od brand and generic drugs

Ultrakind
Ultrakind 250mg TAB / 100
Ultrakind 500mg TAB / 100
Uniklar (Turkey)
URCLAR (India)
URCLAR Capsule/ Tablet / 250mg (10x4 units)$ 12.59
Urclar 250mg TAB / 40$ 14.81
Urclar 500mg SR-TAB / 40$ 28.15
250 mg x 40's$ 14.81
500 mg x 40's$ 28.15
Urclar 250 mg Tablet$ 0.46
URCLAR OD (India)
URCLAR OD Capsule/ Tablet / 500mg (10x4 units)$ 25.19
Urclar OD 500mg TAB / 40$ 25.19
500 mg x 40's$ 25.19
Urclar OD 500 mg Tablet$ 0.80
Urclar SR
Urclar SR 500 mg Tablet$ 0.70
Veclam (Italy)
Vero-Clarithromycin
Tablet, Film-Coated; Oral; Clarithromycin 250 mg
Vick-Clarcid (Hongkong)
Vick-Clarcid 250 mg x 50 x 10's
Vikrol (Mexico)
Tablet; Oral; Clarithromycin 250 mg
Tablet; Oral; Clarithromycin 500 mg
Wei Peng (China)
Winclar (Italy)
Winthrop Clarithromycin (Philippines)
Winthrop Clarithromycin 500 mg x 30's$ 39.75
Wo Ka (China)
Xilin (Ecuador)
Xuclamin
Capsule; Oral; Clarithromycin 250 mg
Capsule; Oral; Clarithromycin 500 mg
Xylar (Tunisia)
Yi Chuang (China)
Yi Hong (China)
Yi Ren (China)
Yu Jun Xian (China)
Zarith
Zarith 250 mg Tablet$ 0.52
Zeclar (Finland, France, Tunisia)
Granules for Suspension; Oral; Clarithromycin 7.5 mg
Injectable; Subcutaneous; Clarithromycin 500 mg
Tablet, Film-Coated; Oral; Clarithromycin 250 mg
Tablet, Film-Coated; Oral; Clarithromycin 500 mg
Zeclaren (Greece)
Zhen Ke (China)
Zhenke (China)
Zymbaktar (Serbia)

Show all Zeclar OD generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer